Results 191 to 200 of about 4,938,261 (300)

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial [PDF]

, 2017
DiPersio, John F, et al,
core   +1 more source

Mutational spectrum defines primary and secondary myelofibrosis

, 2014
Ken Mills, M. F. McMullin
openalex   +2 more sources

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

Journal of Clinical Oncology, 2017
P. Guglielmelli, T. Lasho, G. Rotunno, M. Mudireddy, C. Mannarelli, M. Nicolosi, Annalisa Pacilli, A. Pardanani, E. Rumi, V. Rosti, C. Hanson, F. Mannelli, R. Ketterling, N. Gangat, A. Rambaldi, F. Passamonti, G. Barosi, T. Barbui, M. Cazzola, A. Vannucchi, A. Tefferi   +20 more
semanticscholar   +1 more source

Sweet's syndrome with Koebner phenomenon triggered by G-CSF as a preleukemic manifestation in a patient with primary myelofibrosis: a case report. [PDF]

Front Med (Lausanne)
Zhang Z, Zhou D, Liu Y, Meng L, Ji B.
europepmc   +1 more source

Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study

Olga Vinogradova, M. M. Pankraskina, А. Л. Неверова, Д. И. Шихбабаева, M. A. Murzabekova, M. V. Chernikov, A. G. Popova, В. П. Косенкова, L. B. Egoryan, В. В. Птушкин   +9 more
openalex   +1 more source

Analiza gena i proteina signalnih puteva Wnt i Sonic Hedgehog u primarnoj i sekundarnoj mijelofibrozi [Analysis of genes and proteins of WNT and Sonic Hedgehog signaling pathways in primary and secondary myelofibrosis] [PDF]

, 2017
Marko Lucijanić
openalex  

Chronic Inflammation in Primary Myelofibrosis: In-Depth Insights Into Pathogenesis and Promising Anti-Inflammatory Therapeutic Strategies. [PDF]

Mediators Inflamm
Chen M, Zheng C, Zhang Y, He J, Shi Z.
europepmc   +1 more source

Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients [PDF]

, 2016
Paola Guglielmelli, Giada Rotunno, Annalisa Pacilli, Elisa Rumi, Vittorio Rosti, Federica Delaini, Margherita Maffioli, Tiziana Fanelli, Alessandro Pancrazzi, Lisa Pieri, Rajmonda Fjerza, Daniela Pietra, Daniela Cilloni, Emanuela Sant’Antonio, Silvia Salmoiraghi, Francesco Passamonti, Alessandro Rambaldi, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi   +20 more
openalex   +1 more source

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies [PDF]

, 2014
DiPersio, John F, et al,
core   +1 more source

Primary Myelofibrosis - 7

, 2018
Gloria Kwon, Michelle To
openalex   +1 more source